American College of Toxicology Annual Meeting (ACT 2018)

  • Other
Sunday 04 November 2018 to Wednesday 07 November 2018
Palm Beach, Florida

The American College of Toxicology's annual meeting aims to update attendees on emerging trends in the discipline of toxicology. This year’s meeting will include a diverse scientific programme and a traditional poster reception session for attendees and exhibitors.

Dr Helen Prior will be presenting work on “When would data from a single species be sufficient for safe progression in humans” in Symposium 10: Integration of consortia recommendations for justification of animal use within current and future drug development paradigms’ on Tuesday 6 November 9-12am. Prof Ian Kimber is a co-chair of this session, which was proposed and organised by the NC3Rs to bring together scientists and regulators from four separate industry consortia (IQ-DruSafe, EFPIA, Biosafe and NC3Rs).

Two further posters with results from the NC3Rs/ABPI working group project ‘Review of the use of a second species in regulatory studies’ will be presented, entitled ‘Can we expand the use of one species for post-‘First-in-Human’ (FIH) studies, within and beyond ICHS6?’ and ‘Trends toward a reduction in the use of recovery animals for First-In-Human (FIH) studies from 2013 to 2017.’

We will also have a stand within the exhibition hall (booth number 503). 

For more information, visit the ACT 2018 website.